Piero Ruscitti

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Francesco Carubbi, Paola Cipriani, Alessandra Marrelli et al. · Arthritis Research & Therapy · 2013 · 175 citations · Full text

Immunology, Immunotherapy, Psoriatic Arthritis +23

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma

Elena Pontarini, William Murray‐Brown, Cristina Croia et al. · Annals of the Rheumatic Diseases · 2020 · 175 citations · Full text

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

Piero Ruscitti, Paola Cipriani, Francesco Masedu et al. · BMC Medicine · 2016 · 169 citations · Full text

Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey

Francesco Ursini, Jacopo Ciaffi, Luana Mancarella et al. · RMD Open · 2021 · 137 citations · Full text

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1<b>β</b>via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto et al. · Clinical & Experimental Immunology · 2015 · 131 citations · Full text